| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 142 |
| 1 | INFLIXIMAB | 100 |
| 2 | METHOTREXATE SODIUM | 54 |
| 3 | AZATHIOPRINE | 40 |
| 4 | ADALIMUMAB-ADAZ | 37 |
| 5 | PREDNISONE | 35 |
| 6 | ADALIMUMAB-AATY | 31 |
| 7 | TACROLIMUS | 31 |
| 8 | ADALIMUMAB-FKJP | 30 |
| 9 | METHOTREXATE | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), GLYCOPEGYLATED-EXEI | 1 | 0.0130 |
| 1 | APADAMTASE ALFA | 1 | 0.0127 |
| 2 | INFLIXIMAB-DYYB | 26 | 0.0075 |
| 3 | ADALIMUMAB-RYVK | 2 | 0.0018 |
| 4 | TERBINAFINE TABLETS 250 MG | 2 | 0.0016 |
| 5 | PURIXAN | 1 | 0.0013 |
| 6 | DISOPYRAMIDE PHOSPHATE | 1 | 0.0012 |
| 7 | DARIFENACIN HYDROBROMIDE | 1 | 0.0012 |
| 8 | CEFOTAXIME INJECTION | 5 | 0.0011 |
| 9 | RIFABUTIN | 3 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 127 |
| 1 | Corticosteroid [EPC] | 61 |
| 2 | Purine Antimetabolite [EPC] | 40 |
| 3 | Atypical Antipsychotic [EPC] | 29 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 29 |
| 5 | Interleukin-12 Antagonist [EPC] | 26 |
| 6 | Interleukin-23 Antagonist [EPC] | 26 |
| 7 | Benzodiazepine [EPC] | 24 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 23 |
| 9 | Osmotic Laxative [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Rifamycin Antimycobacterial [EPC] | 3 | 0.0009 |
| 1 | Selective T Cell Costimulation Blocker [EPC] | 3 | 0.0006 |
| 2 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 3 | Purine Antimetabolite [EPC] | 40 | 0.0004 |
| 4 | Monoamine Oxidase Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Interleukin-12 Antagonist [EPC] | 26 | 0.0003 |
| 6 | Interleukin-23 Antagonist [EPC] | 26 | 0.0002 |
| 7 | Antimycobacterial [EPC] | 6 | 0.0002 |
| 8 | Asparagine-specific Enzyme [EPC] | 3 | 0.0002 |
| 9 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |